[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335949-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335949-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-noncoding-rna-linc00921-serves-as-a-predictive-biomarker-for-lung-adenocarcinoma-an-observational-study","Long noncoding RNA LINC00921 serves as a predictive biomarker for lung adenocarcinoma - An observational study","","Lung adenocarcinoma (LUAD) is often diagnosed at advanced stages, creating a need for effective biomarkers to predict disease status. This observational study evaluates long noncoding RNA LINC00921 in LUAD using Cancer Genome Atlas gene expression data. Diagnostic, survival, tumor mutational burden, and immune cell infiltration analyses are performed, and patients are stratified by median LINC00921 expression. Functional enrichment, differential analysis, and drug screening are combined, with validation by blood real-time PCR. Results indicate lower LINC00921 in LUAD, and reduced expression associates with poorer prognosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-noncoding-rna-linc00921-serves-as-a-predictive-biomarker-for-lung-adenocarcinoma-an-observational-study/335949/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-noncoding-rna-linc00921-serves-as-a-predictive-biomarker-for-lung-adenocarcinoma-an-observational-study/335949.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study on LINC00921 in LUAD?","Question",{"text":63,"@type":64},"To determine whether long noncoding RNA LINC00921 can serve as a predictive biomarker for lung adenocarcinoma and clarify its relationship with diagnosis, prognosis, and tumor features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients grouped for the analyses?",{"text":68,"@type":64},"Patients were divided into LINC00921 high- and low-expression groups based on the median LINC00921 expression value.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings link LINC00921 expression to patient outcomes?",{"text":72,"@type":64},"LINC00921 is significantly lower in LUAD tumor tissues, and low LINC00921 expression corresponds to a shorter median survival time, alongside decreased immune cell infiltration in the tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335949,1790023502,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","®  \n Observational Study   \nLong noncoding RNA LINC00921 serves as a predictive biomarker for lung adenocarcinoma An observational study  \nHongyu Xu, MDa ,* , Weijie Xiong, MSb , Xianguo Liu, BSa , Yang Wang, MSa , Maolin Shi, MSa , Yuhui Shi, MSa , Jia Shui, BSa , Yanxin Yu, MSa  \n\n| Abstract\u003Cbr>Lung adenocarcinoma (LUAD) is usually diagnosed at advanced stages. Hence, there is an urgent need to seek an effective biomarker to predict LUAD status. Long noncoding RNAs (lncRNAs) play key roles in the development of tumors. However, the relationship between LINC00921 and LUAD remains unclear. The gene expression data of LUAD were downloaded from the Cancer Genome Atlas database to investigate the expression level of LINC00921 in LUAD. Diagnostic ability analysis, survival analysis, tumor mutational burden analysis, and immune cell infiltration analysis of LINC00921 in LUAD patients were performed simultaneously. According to the median expression value of LINC00921 , patients were divided into LINC00921 high-and low-expression groups. The function of LINC00921 in LUAD was identified through difference analysis and enrichment analysis. Moreover, drugs that may be relevant to LUAD treatment were screened. Finally, blood samples were collected for real-time polymerase chain reaction. LINC00921 was significantly lower in LUAD tumor tissues. Notably, patients with low expression of LINC00921 had a shorter median survival time. Decreased immune cell infiltration in the tumor microenvironment in the low LINC00921 expression group may contribute to poorer patient outcomes. Tumor mutational burden was significantly different in survival between the LINC00921 high-and low-expression groups. In addition, LINC00921 may exert an influence on cancer development through its regulation of target genes transcription. Glyceraldehyde-3-phosphate dehydrogenase-related drugs may be more likely to be therapeutically effective in LUAD. LINC00921 was able to be used as the potential diagnostic indicator for LUAD. |\n| --- |\n| Abbreviations: Cor = Pearson correlation coefficient, DEG = differentially expressed gene, FDR = false discovery rate, lncRNA = long noncoding RNA, LUAD = lung adenocarcinoma, NSCLC = nonsmall cell lung cancer, GO = gene ontology, PCG = protein-coding gene, ROC = receiver operating characteristic, SCLC = small cell lung cancer, ssGSEA = single-sample gene set enrichment analysis, TCGA = the Cancer Genome Atlas, TIME = tumor immune microenvironment, TMB = tumor mutational burden. |\n| Keywords: biomarkers, LINC00921 , lncRNAs, lung adenocarcinoma, prognostic diagnosis |\n\n1. Introduction  \nLung cancer is widely recognized as the most prevalent form of cancer globally.[1] Nonsmall cell lung cancer (NSCLC) constitutes the majority, approximately 85%, of primary lung cancer cases.[2] Lung adenocarcinoma (LUAD), with characterization of high metastasis and mortality, is a dominating subtype of NSCLC, and its incidence has been steadily increasing over the years.[3] It is imperative to acknowledge that LUAD exhibits significant variations in pedigree. Recent studies have shown that individuals of East Asian ancestry with LUAD exhibit a comparatively more stable genome than individuals of European  \nancestry.[4] Moreover, smokers have a higher prevalence of LUAD.  \nAn estimated 1.4 million lung cancer patients die from lung cancer each year, the highest mortality rate among all types of cancer.[2] The primary factor contributing to the elevated mortality rate is the advanced stage of lung cancer diagnosis in the majority of patients.[5,6] Some prognostic methods exhibit restricted efficacy, and achieving early detection continues tobe a challenging objective. Recently, there has been significant progress in our understanding of tumor biology due to advancements in biomedical technology.[7]  \nThis study was funded by Chengdu Health Commission Fund (2022485) and General Healthcare Scientific Research Fund Program (TYYLKYJJ-2022-044).  \nAll aut","cbCailzFur63CQx4","https://ap.wps.com/l/cbCailzFur63CQx4","pdf",2838487,11,"English","# Introduction\n## Lung cancer burden and diagnostic challenges\n# Study Overview\n## Data source and LINC00921 expression grouping\n## Analyses: diagnosis, survival, TMB, immune infiltration\n## Functional enrichment and drug screening\n## Experimental validation by real-time PCR\n# Abbreviations and Keywords","[{\"question\":\"What is the main goal of the study on LINC00921 in LUAD?\",\"answer\":\"To determine whether long noncoding RNA LINC00921 can serve as a predictive biomarker for lung adenocarcinoma and clarify its relationship with diagnosis, prognosis, and tumor features.\"},{\"question\":\"How were patients grouped for the analyses?\",\"answer\":\"Patients were divided into LINC00921 high- and low-expression groups based on the median LINC00921 expression value.\"},{\"question\":\"What key findings link LINC00921 expression to patient outcomes?\",\"answer\":\"LINC00921 is significantly lower in LUAD tumor tissues, and low LINC00921 expression corresponds to a shorter median survival time, alongside decreased immune cell infiltration in the tumor microenvironment.\"}]","Long noncoding RNA LINC00921 serves as a predictive biomarker for lung adenocarcinoma - An observational study | PDF",1790012907,28]